Before I start, let me get two things out of the way. First, in no way am I the caller of market tops and bottoms — and that’s not the intent of this article. …

The globalization that began during the 1990s and flourished into this millennia reshaped aspects of our lives in ways we are only now appreciating. Many of these changes were net positive: cheaper goods increased domestic purchasing power, ultimately improving the quality of life for many Americans. More concerningly, as globalization…

KdT has recently been exploring alternative data sharing incentive structures, since as a firm we believe the greatest advancements in science and medicine this century will come from our understanding of pre-existing, siloed data as well as data produced and enabled by the scientific revolution we are currently undergoing. This…

As we continue to digest the news from Zymergen and its reverberations across the Synthetic Biology ecosystem, we wanted to take a moment to reflect in writing. Let’s start with a statement: We steadfastly believe we are in the golden age of biology. Our conviction is driven by the unparalleled…

Content is king (or so my kids tell me). We would like to be able to say that we have a grand plan in mind behind launching curated content at KdT, including our new podcast series, The World in a Grain of Sand. But really we just want to share…

Today we’re announcing the closing of our $50M Fund II for KdT Ventures. With the announcement, one important aspect is obvious: with this fresh capital, we will double down on supporting the earliest stages of a new wave of scientist-entrepreneurs fusing data, engineering, and science to solve previously intractable problems. …

N.B.- As a reminder, we are a seed-stage firm so our views relate to companies at that seed stage. Many early stage founders balance seeking commercial validation while remaining product focused. Specifically, startups must juggle the need/desire to validate the platform through partnering/licensing a (lessor) component thereof against the need/desire…

Lately, it feels like a disproportionately large number of companies we have seen at KdT deploy or manipulate microfluidic technology of various flavors (continuous flow, droplet based, digital, etc…). For a field that has its origins in inkjet printing back in the 1970s, the team has internally been asking —…

Before jumping in headfirst, it’s important to acknowledge relevant qualifiers: KdT Ventures is a seed stage venture firm and thus this article relates to seed stage companies This is primarily written for “platform” companies and not single asset companies Every company is unique and based on that uniqueness certain companies…